bf/NYSE:LLY_icon.png

COM:LILLY

Eli Lilly and Company

  • Stock

USD

Last Close

749.92

22/11 21:00

Market Cap

893.17B

Beta: -

Volume Today

4.01M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
2.79B
-
2.83B
1.73%
3.09B
9.12%
3.50B
13.29%
4.01B
14.45%
3.78B
5.78%
3.14B
16.78%
3.59B
14.03%
3.93B
9.70%
4.10B
4.19%
5.04B
23.02%
average payables
1.15B
-
1.12B
2.61%
1.23B
9.74%
1.34B
8.97%
1.38B
2.70%
1.31B
5.15%
1.31B
0.21%
1.51B
15.30%
1.64B
8.81%
1.80B
9.88%
2.26B
25.77%
average receivables
3.96B
-
3.91B
1.10%
3.94B
0.62%
4.42B
12.26%
5.01B
13.47%
5.52B
10.08%
5.66B
2.53%
6.24B
10.18%
7.53B
20.73%
8.34B
10.83%
9.95B
19.23%
book value per share
16.31
-
14.37
11.92%
13.72
4.50%
13.24
3.54%
11.02
16.75%
9.56
13.21%
2.80
70.72%
6.22
122.00%
9.90
59.28%
11.81
19.29%
11.93
0.97%
capex per share
-1.01
-
-1.46
44.69%
-1.53
4.64%
-1.03
32.62%
-2.06
99.32%
-2.94
42.80%
-1.45
50.50%
-2.24
53.78%
-2.07
7.61%
-2.75
33.38%
-8.18
197.08%
capex to depreciation
-0.76
-
-1.14
50.14%
-1.14
0.31%
-0.73
35.94%
-1.38
89.19%
-1.88
35.88%
-1.10
41.46%
-1.53
39.58%
-1.21
21.03%
-1.63
34.79%
-4.84
196.65%
capex to operating cash flow
-0.19
-
-0.36
88.09%
-0.59
63.56%
-0.23
61.62%
-0.39
71.15%
-0.55
41.80%
-0.28
48.78%
-0.31
11.56%
-0.26
17.36%
-0.35
35.91%
-1.74
397.21%
capex to revenue
-0.05
-
-0.08
68.76%
-0.08
2.07%
-0.05
36.85%
-0.09
83.85%
-0.14
48.44%
-0.06
56.82%
-0.08
36.35%
-0.07
20.00%
-0.09
31.57%
-0.22
148.90%
cash per share
4.99
-
4.51
9.65%
4.19
7.08%
5.71
36.10%
7.64
33.84%
7.21
5.60%
2.62
63.67%
4.06
54.86%
4.31
6.25%
2.45
43.08%
3.24
32.14%
days of inventory on hand
217.81
-
202.76
6.91%
249.69
23.15%
229.91
7.92%
268.08
16.60%
241.54
9.90%
246.68
2.13%
264.95
7.41%
193.96
26.79%
237.27
22.33%
320.42
35.04%
days payables outstanding
83.24
-
83.48
0.29%
96.97
16.16%
87.09
10.18%
84.83
2.60%
94.11
10.95%
108.64
15.45%
106.95
1.56%
83.38
22.04%
106.29
27.47%
144.25
35.71%
days sales outstanding
63.53
-
70.73
11.34%
74.46
5.27%
81.98
10.09%
83.98
2.44%
98.10
16.82%
90.62
7.62%
103.06
13.73%
104.75
1.64%
109.45
4.49%
121.25
10.78%
debt to assets
0.15
-
0.22
46.53%
0.22
3.51%
0.27
18.39%
0.30
14.25%
0.23
22.69%
0.40
71.51%
0.36
11.54%
0.35
2.79%
0.33
5.16%
0.39
20.11%
debt to equity
0.30
-
0.52
77.25%
0.55
4.48%
0.74
34.36%
1.18
60.02%
1.05
11.00%
6.06
478.57%
2.94
51.48%
1.88
36.07%
1.52
18.91%
2.34
53.58%
dividend yield
0.04
-
0.03
26.01%
0.02
16.48%
0.03
16.64%
0.02
11.03%
0.02
21.21%
0.02
1.31%
0.02
10.96%
0.01
29.73%
0.01
13.01%
0.01
27.89%
earnings yield
0.08
-
0.03
61.89%
0.03
16.89%
0.04
30.66%
-0.00
106.53%
0.03
1,283.10%
0.04
39.46%
0.04
6.64%
0.02
44.87%
0.02
15.04%
0.01
47.42%
enterprise value
56.51B
-
78.00B
38.03%
93.79B
20.24%
83.56B
10.90%
95.96B
14.84%
121.91B
27.03%
135.84B
11.43%
166.18B
22.34%
263.59B
58.61%
344.06B
30.53%
548.95B
59.55%
enterprise value over ebitda
10.80
-
19.51
80.60%
20.87
6.94%
19.51
6.51%
12.43
36.25%
12.64
1.64%
20.57
62.72%
21.75
5.75%
30.16
38.69%
36.47
20.92%
44.07
20.84%
ev to operating cash flow
9.85
-
17.86
81.27%
33.82
89.38%
17.23
49.07%
17.09
0.79%
22.07
29.13%
28.08
27.27%
25.57
8.96%
36.30
41.99%
48.57
33.78%
129.47
166.58%
ev to sales
2.44
-
3.98
62.65%
4.70
18.18%
3.94
16.21%
4.20
6.56%
5.67
35.18%
6.09
7.30%
6.77
11.27%
9.31
37.45%
12.05
29.51%
16.09
33.45%
free cash flow per share
4.29
-
2.62
39.03%
1.08
58.76%
3.55
228.95%
3.28
7.62%
2.44
25.68%
3.74
53.40%
4.93
31.66%
5.94
20.60%
5.10
14.11%
-3.49
168.40%
free cash flow yield
0.08
-
0.04
54.93%
0.01
66.23%
0.05
276.85%
0.04
19.55%
0.02
45.76%
0.03
35.07%
0.03
2.49%
0.02
26.28%
0.01
35.15%
-0.01
142.93%
graham net net
-7.15
-
-11.91
66.54%
-11.07
7.09%
-12.60
13.84%
-18.16
44.16%
-19.18
5.61%
-30.50
59.04%
-32.99
8.15%
-30.55
7.40%
-30.97
1.39%
-42.98
38.78%
graham number
39.88
-
26.88
32.62%
26.46
1.54%
27.75
4.89%
6.94
75.01%
26.01
275.08%
17.71
31.90%
30.89
74.39%
37.03
19.85%
42.90
15.86%
39.45
8.03%
income quality
1.22
-
1.83
49.23%
1.15
36.98%
1.77
53.91%
-27.51
1,652.72%
1.71
106.21%
0.58
65.98%
1.05
80.48%
1.30
23.96%
1.13
12.79%
0.81
28.68%
intangibles to total assets
0.12
-
0.12
1.62%
0.26
104.32%
0.21
15.86%
0.19
13.02%
0.06
70.31%
0.26
372.73%
0.24
8.24%
0.24
1.32%
0.23
3.97%
0.19
18.80%
interest coverage
33.54
-
17.88
46.71%
16.68
6.67%
18.68
11.94%
9.53
48.95%
22.74
138.50%
12.42
45.39%
16.85
35.67%
18.71
11.05%
21.49
14.89%
33.06
53.82%
interest debt per share
4.97
-
7.67
54.27%
7.67
0.05%
9.91
29.32%
13.19
33.03%
10.29
22.00%
17.40
69.21%
18.68
7.33%
18.99
1.67%
18.38
3.24%
28.27
53.85%
inventory turnover
1.68
-
1.80
7.42%
1.46
18.80%
1.59
8.60%
1.36
14.24%
1.51
10.99%
1.48
2.08%
1.38
6.90%
1.88
36.60%
1.54
18.25%
1.14
25.95%
invested capital
0.30
-
0.52
77.25%
0.55
4.48%
0.74
34.36%
1.18
60.02%
1.05
11.00%
6.06
478.57%
2.94
51.48%
1.88
36.07%
1.52
18.91%
2.34
53.58%
market cap
55.12B
-
73.81B
33.91%
89.48B
21.22%
77.84B
13.01%
88.85B
14.15%
118.93B
33.85%
122.37B
2.89%
153.24B
25.23%
250.52B
63.48%
329.89B
31.68%
526.54B
59.61%
net current asset value
-4.50B
-
-9.61B
113.41%
-8.40B
12.54%
-9.62B
14.50%
-14.11B
46.62%
-12.45B
11.77%
-22.88B
83.76%
-23.35B
2.05%
-21.20B
9.20%
-20.68B
2.45%
-27.42B
32.57%
net debt to ebitda
0.26
-
1.05
295.99%
0.96
8.36%
1.34
39.26%
0.92
31.03%
0.31
66.49%
2.04
560.38%
1.69
16.95%
1.50
11.70%
1.50
0.48%
1.80
19.75%
net income per share
4.33
-
2.23
48.45%
2.27
1.51%
2.59
14.05%
-0.19
107.50%
3.14
1,720.98%
4.98
58.40%
6.82
36.99%
6.15
9.81%
6.93
12.53%
5.80
16.23%
operating cash flow per share
5.31
-
4.08
23.07%
2.61
36.03%
4.58
75.54%
5.34
16.46%
5.38
0.70%
5.19
3.36%
7.16
37.85%
8.01
11.79%
7.86
1.86%
4.69
40.25%
payables turnover
4.38
-
4.37
0.29%
3.76
13.91%
4.19
11.34%
4.30
2.67%
3.88
9.87%
3.36
13.38%
3.41
1.58%
4.38
28.26%
3.43
21.55%
2.53
26.31%
receivables turnover
5.75
-
5.16
10.19%
4.90
5.01%
4.45
9.17%
4.35
2.39%
3.72
14.40%
4.03
8.25%
3.54
12.07%
3.48
1.62%
3.33
4.30%
3.01
9.73%
research and ddevelopement to revenue
0.24
-
0.24
0.84%
0.24
0.42%
0.25
2.82%
0.23
6.54%
0.24
1.77%
0.25
6.67%
0.25
1.07%
0.25
0.04%
0.25
1.55%
0.27
8.33%
return on tangible assets
0.15
-
0.07
51.51%
0.09
23.72%
0.09
1.18%
-0.01
106.21%
0.08
1,496.75%
0.16
105.30%
0.17
9.31%
0.15
14.25%
0.16
8.99%
0.10
38.53%
revenue per share
21.38
-
18.33
14.26%
18.80
2.52%
20.05
6.69%
21.74
8.42%
20.91
3.80%
23.97
14.63%
27.04
12.79%
31.22
15.48%
31.65
1.37%
37.78
19.36%
roe
0.27
-
0.16
41.48%
0.17
6.29%
0.20
18.24%
-0.02
109.01%
0.33
1,967.66%
1.78
441.03%
1.10
38.29%
0.62
43.38%
0.59
5.67%
0.49
17.03%
roic
0.19
-
0.09
51.63%
0.10
13.82%
0.12
12.12%
-0.01
106.84%
0.26
3,433.73%
0.23
11.90%
0.23
0.67%
0.22
4.50%
0.24
9.12%
0.23
5.70%
sales general and administrative to revenue
0.31
-
0.34
9.48%
0.33
3.02%
0.30
7.12%
0.29
5.25%
0.28
3.49%
0.28
0.15%
0.25
10.40%
0.23
8.95%
0.23
0.65%
0.20
9.86%
shareholders equity per share
16.31
-
14.37
11.92%
13.72
4.50%
13.24
3.54%
11.02
16.75%
9.56
13.21%
2.80
70.72%
6.22
122.00%
9.90
59.28%
11.81
19.29%
11.93
0.97%
stock based compensation to revenue
0.01
-
0.01
26.86%
0.01
37.22%
0.01
10.24%
0.01
2.24%
0.01
5.73%
0.01
7.63%
0.01
10.30%
0.01
3.58%
0.01
7.41%
0.02
41.65%
tangible asset value
13.31B
-
10.75B
19.26%
5.52B
48.67%
5.75B
4.25%
3.27B
43.15%
8.47B
159.27%
-7.60B
189.66%
-5.39B
29.05%
-2.43B
54.94%
-504.20M
79.24%
-982.60M
94.88%
tangible book value per share
12.31
-
10.04
18.44%
5.19
48.28%
5.43
4.60%
3.11
42.81%
8.25
165.40%
-8.16
198.97%
-5.94
27.21%
-2.68
54.91%
-0.56
79.12%
-1.09
94.55%
working capital
4.19B
-
972.30M
76.78%
4.34B
346.78%
4.11B
5.28%
4.67B
13.40%
8.66B
85.62%
1.93B
77.67%
4.98B
157.47%
3.40B
31.74%
896.30M
73.64%
-1.57B
274.74%

All numbers in USD (except ratios and percentages)